Olink Holding AB (publ)
OLK
Kedudukan dalam Saham
#4813
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
Harga Saham
$26.08
Disegerakkan terakhir: 2024-07-09
Modal Pasaran
$3.10B
Perubahan (1 hari)
0.31%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Olink Holding AB (publ) (OLK)
Kategori
Healthcare
Hasil untuk Olink Holding AB (publ) (OLK)
Hasil pada Mar 2024 TTM: $171.45M
Menurut laporan kewangan terkini daripada Olink Holding AB (publ), hasil semasa syarikat (TTM) ialah $171.45M. Pada tahun 2022, syarikat memperoleh hasil sebanyak $139.85M peningkatan berbanding hasil pada tahun 2021 iaitu $94.97M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Olink Holding AB (publ) dari 2019 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $171.45M | 0.91% |
| 2023 | $169.91M | 21.49% |
| 2022 | $139.85M | 47.25% |
| 2021 | $94.97M | 75.66% |
| 2020 | $54.07M | 29.68% |
| 2019 | $41.69M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $46.34B | 26,926.59% |
US
|
|
| $25.11B | 14,544.26% |
US
|
|
| $2.71B | 1,478.97% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 4,199.90% |
US
|
